Vanda Pharmaceuticals, Inc. (VNDA)
7.25
+0.43
(+6.30%)
USD |
NASDAQ |
Mar 25, 16:00
7.10
-0.15
(-2.07%)
Pre-Market: 08:39
Vanda Pharmaceuticals Cash from Investing (Quarterly) : 44.87M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -2.802B |
| Gilead Sciences, Inc. | -1.835B |
| Axsome Therapeutics, Inc. | -0.071M |
| Gossamer Bio, Inc. | 73.16M |
| Arcellx, Inc. | 57.80M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.42M |
| Cash from Financing (Quarterly) | -0.64M |
| Free Cash Flow | -110.44M |
| Free Cash Flow Per Share (Quarterly) | -0.4995 |
| Free Cash Flow to Equity (Quarterly) | -31.23M |
| Free Cash Flow to Firm (Quarterly) | -29.52M |
| Free Cash Flow Yield | -25.85% |